Estimation of clinically significant prostate volumes by digital rectal examination: A comparative prospective study

Canadian Journal of Urology

Volumn 18, Issue 6, 2011, Pages 6025-6030

  Ahmad, Sarfraz ^a   Manecksha, Rustom Pervez ^a   Cullen, Ivor Michael ^a   Flynn, Robert Joseph ^a   Dermott McDermott, Thomas Eugene ^a   Grainger, Ronald ^a   Thornhill, John Alan ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

BPH; Digital rectal examination; Prostate volume

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DIGITAL RECTAL EXAMINATION; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROSTATE; PROSTATE HYPERTROPHY; REPRODUCIBILITY; URETHRA;

ADULT; AGED; AGED, 80 AND OVER; DIGITAL RECTAL EXAMINATION; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC HYPERPLASIA; REPRODUCIBILITY OF RESULTS; URETHRA;

EID: 84860237804     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Roehrborn CG, Sech S, Montoya J, Rhodes T, Girman CJ. Interexaminer reliability and validity of a three-dimensional model to assess prostate volume by digital rectal examination. Urology 2001;57(6):1087-1092.
2. Nickel JC. Benign prostatic hyperplasia: does prostate size matter? Rev Urol 2003;5(Suppl 4):S12-S17.
3. Babaian RJ, Fritsche HA, Evans RB. Prostate-specific antigen and prostate gland volume: correlation and clinical application. J Clin Lab Anal 1990;4(2):135-137.
4. Roehrborn CG, Chinn HK, Fulgham PF, Simpkins KL, Peters PC. The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy. J Urol 1986;135(6):1190-1193.
5. McConnell JD, Roehrborn CG, Bautista OM et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349(25):2387-2398.
6. Roehrborn CG, Siami P, Barkin J et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol 2010;57(1):123-131.
7. Loeb S, Han M, Roehl KA, Antenor JA, Catalona WJ. Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography. J Urol 2005;173(1):63-65.
8. Roehrborn CG: Accurate determination of prostate size via digital rectal examination and transrectal ultrasound. Urology 1998;51(4A Suppl):19-22.
9. Sech S, Montoya J, Girman CJ, Rhodes T, Roehrborn CG. Interexaminer reliability of transrectal ultrasound for estimating prostate volume. J Urol 2001;166(1):125-129.
10. Collins GN, Raab GM, Hehir M, King B, Garraway WM. Reproducibility and observer variability of transrectal ultrasound measurements of prostatic volume. Ultrasound Med Biol 1995;21(9):1101-1105.
11. Roehrborn CG, Girman CJ, Rhodes T et al. Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology 1997;49(4):548-557.
12. Yamamoto T, Ito K, Ohi M et al. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less. Urology 2001;58(6):994-998.
13. Richie JP, Catalona WJ, Ahmann FR et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology 1993;42(4):365-374.
14. Potter SR, Horniger W, Tinzl M, Bartsch G, Partin AW. Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. Urology 2001;57(6):1100-1104.